Search Login Register
sobuzoxane
Summary
33
relevant articles (10 outcomes,
11 trials/studies)
found for this Bio-Agent
Description:
used in treatment of leukemia L1210
Also Known As:
1,2-bis(4-isobutoxycarbonyloxymethyl-3,5-dioxopiperazin-1-yl)ethane; MST 16; MST-16
Key Diseases for which sobuzoxane is
Relevant
-
Lymphoma (Lymphomas)
:
4 outcomes 5 studies in 10 results
-
Adult T-Cell Leukemia-Lymphoma (T-ALL)
:
4 outcomes 4 studies in 9 results
-
Leukemia
:
2 outcomes in 2 results
-
Leukemia L1210
:
1 outcome 2 studies in 5 results
-
Neoplasms (Cancer)
:
1 outcome 1 study in 8 results
Show All >>
Drugs Related to sobuzoxane
-
sobuzoxane
-
Type II DNA Topoisomerases (Topoisomerase II)
-
Etoposide (VP 16)
-
Razoxane (Dexrazoxane)
-
Granulocyte Colony-Stimulating Factor (G-CSF)
-
Vincristine (Oncovin)
-
Antineoplastic Agents (Antineoplastics)
-
1,2-bis(3,5-dioxopiperazin-1-yl)ethane
-
Methotrexate (Mexate)
-
Hydrocortisone (Cortisol)
Show All >>
Therapies Related to sobuzoxane
-
Heterologous Transplantation (Xenotransplantation)
-
Combination Drug Therapy (Combination Chemotherapy)
-
Drug Therapy (Chemotherapy)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.